Study Of Perennial Allergic Rhinitis

• Status: Completed
• Trial end date: 2005-10-12
• Target enrollment: 0
• Participant gender: All

Summary

This study was designed to assess safety of an investigational nasal spray in the treatment of perennial allergic rhinitis. Perennial allergic rhinitis is triggered by house dust, mite and mold etc. Typical symptoms are sneezing, nasal congestion and pruritus and rhinorrhea.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline

Criteria

Inclusion criteria:

• Informed consent.

• Outpatient.

• Diagnosis of perennial allergic rhinitis with symptoms.

• Able to comply with study procedures.

Exclusion criteria:

• Significant concomitant medical condition.

• Use of corticosteroids/allergy medications.

• Laboratory abnormality.

• Positive pregnancy test.